Skip to content

In the BioHarmony Drug Report Database

Botulinum toxin type b

Myobloc, NeuroBloc (botulinum toxin type b) is an unknown pharmaceutical. Botulinum toxin type b was first approved as Myobloc on 2001-01-22. It is used to treat sialorrhea in the USA. It has been approved in Europe to treat torticollis.
Trade Name NeuroBloc
Common Name Botulinum toxin type b
Indication sialorrhea, torticollis
Drug Class Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)
Botulinum toxin type b
Get full access now